Key facts
- Iroquois Capital Management, LLC filed SCHEDULE 13G for Petros Pharmaceuticals, Inc. Common Stock, $0.0001 par value (PTPI).
- Disclosed ownership: 10%.
- Date of event: 17 Feb 2025.
Iroquois Capital Management, LLC - 17 Feb 2025 SCHEDULE 13G Report for Petros Pharmaceuticals, Inc. Common Stock, $0.0001 par value (PTPI)
- Filing Manager
- Iroquois Capital Management, LLC
- Reporting Manager
- Richard Abbe
- Symbol
- PTPI
- Shares outstanding
- 25,296,136 shares
- Disclosed Ownership
- 2,527,084 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 26 Feb 2025, 09:16:13 UTC
- Date of event
- 17 Feb 2025
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Key filing fact
Iroquois Capital Management, LLC disclosed 10% ownership in Petros Pharmaceuticals, Inc. Common Stock, $0.0001 par value (PTPI) on 17 Feb 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 26 Feb 2025, 09:16.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 3.6% | 902,084 | 0 | 902,084 | /s/ Richard Abbe | Richard Abbe, President | |
| Richard Abbe | 10% | 2,527,084 | 1,652,084 | 902,084 | /s/ Richard Abbe | Richard Abbe | |
| Kimberly Page | 3.6% | 902,084 | 0 | 902,084 | /s/ Kimberly Page | Kimberly Page |
CIK / CUSIP context first